0001144204-19-007974 Sample Contracts

AMENDMENT NO. 2 TO THE STOCK PURCHASE AGREEMENT

Stock Purchase Agreement • February 14th, 2019 • Rezolute, Inc. • Pharmaceutical preparations • California

• Contract Type
  Stock Purchase Agreement
• Filed
  February 14th, 2019
• Company
  Rezolute, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

THIS AMENDMENT NO. 2 (this “Amendment”) to that certain Common Stock Purchase Agreement dated as of December 6, 2017, by and between XOMA (US) LLC, a Delaware limited liability company (“XOMA”), having an address of 2200 Powell Street, Suite 310, Emeryville, CA 94608 and Rezolute, Inc. (formerly known as AntriaBio, Inc.), a Delaware corporation (“Rezolute”), having an address of 1450 Infinite Drive, Louisville, CO 80027, as amended by Amendment No. 1 dated March 30, 2018 (the “Stock Purchase Agreement”), is entered into by and between XOMA and Rezolute effective as of January 7, 2019 (the “Effective Date”). Each of XOMA and Rezolute may be referred to herein as a “Party”, or jointly as the “Parties”. Terms used but not otherwise defined herein shall have the meanings ascribed to them in the License Agreement.

REZOLUTE, INC. PURCHASE AGREEMENT FOR SHARES OF SERIES AA PREFERRED STOCK

Purchase Agreement for Shares of Series Aa Preferred Stock • February 14th, 2019 • Rezolute, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Purchase Agreement for Shares of Series Aa Preferred Stock
• Filed
  February 14th, 2019
• Company
  Rezolute, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

AMENDMENT NO. 2 TO THE LICENSE AGREEMENT

License Agreement • February 14th, 2019 • Rezolute, Inc. • Pharmaceutical preparations • California

• Contract Type
  License Agreement
• Filed
  February 14th, 2019
• Company
  Rezolute, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

THIS AMENDMENT NO. 2 (this “Amendment”) to that certain License Agreement dated as of December 6, 2017, by and between XOMA (US) LLC, a Delaware limited liability company (“XOMA”), having an address of 2200 Powell Street, Suite 310, Emeryville, CA 94608 and Rezolute, Inc. (formerly known as AntriaBio, Inc.), a Delaware corporation (“Rezolute”), having an address of 1450 Infinite Drive, Louisville, CO 80027, as amended by Amendment No. 1 dated March 30, 2018 (the “License Agreement”), is entered into by and between XOMA and Rezolute effective as of January 7, 2019 (the “Effective Date”). Each of XOMA and Rezolute may be referred to herein as a “Party”, or jointly as the “Parties”. Terms used but not otherwise defined herein shall have the meanings ascribed to them in the License Agreement.